##  [Novartis receives three new FDA approvals for the expanded use of Ilaris for patients with rare Periodic Fever Syndrome conditions](/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions-0 "Novartis receives three new FDA approvals for the expanded use of Ilaris for patients with rare Periodic Fever Syndrome conditions") 

  Sep 23, 2016